Molecular pathophysiology of Parkinson's disease

被引:963
|
作者
Moore, DJ [1 ]
West, AB
Dawson, VL
Dawson, TM
机构
[1] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA
关键词
alpha-synuclein; parkin; mitochondrial complex-I; ubiquitin-proteasome system; oxidative stress;
D O I
10.1146/annurev.neuro.28.061604.135718
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic neurons in the substantia nigra. Although the etiology of PD is incompletely understood, the recent discovery of genes associated with rare monogenic forms of the disease, together with earlier studies and new experimental animal models, has provided important and novel insight into the molecular pathways involved in disease pathogenesis. Increasing evidence indicates that deficits in mitochondrial function, oxidative and nitrosative stress, the accumulation of aberrant or misfolded proteins, and ubiquitin-proteasome system dysfunction may represent the principal molecular pathways or events that commonly underlie the pathogenesis of sporadic and familial forms of PD.
引用
收藏
页码:57 / 87
页数:31
相关论文
共 50 条
  • [31] Pathophysiology of Parkinson's disease: Contribution of functional neuroimaging
    Sawamoto, Nobukatsu
    NEUROSCIENCE RESEARCH, 2006, 55 : S16 - S16
  • [32] Pathophysiology and treatment of psychosis in Parkinson's disease - A review
    Zahodne, Laura B.
    Fernandez, Hubert H.
    DRUGS & AGING, 2008, 25 (08) : 665 - 682
  • [33] Psychosis in Parkinson’s Disease: Epidemiology, Pathophysiology, and Management
    Anna Chang
    Susan H. Fox
    Drugs, 2016, 76 : 1093 - 1118
  • [34] Studying the Pathophysiology of Parkinson's Disease Using Zebrafish
    Barnhill, Lisa M.
    Murata, Hiromi
    Bronstein, Jeff M.
    BIOMEDICINES, 2020, 8 (07)
  • [35] Cerebellar involvement in Parkinson’s disease: Pathophysiology and neuroimaging
    Qiu Tao
    Liu Meichen
    Qiu Xinhui
    Li Tianbai
    Le Weidong
    中华医学杂志英文版, 2024, 137 (20)
  • [36] Parkinson's Disease: Epidemiology, Pathophysiology, and Exercise Intervention
    Bollinger, Lance M.
    Cowan, Celsi E.
    LaFontaine, Thomas P.
    STRENGTH AND CONDITIONING JOURNAL, 2012, 34 (02) : 50 - 54
  • [37] Parkinson's Disease: A Review from Pathophysiology to Treatment
    Marino, Bianca L. B.
    de Souza, Lucilene R.
    Sousa, Kessia P. A.
    Ferreira, Jaderson, V
    Padilha, Elias C.
    da Silva, Carlos H. T. P.
    Taft, Carlton A.
    Hage-Melim, Lorane I. S.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (09) : 754 - 767
  • [38] Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management
    Chang, Anna
    Fox, Susan H.
    DRUGS, 2016, 76 (11) : 1093 - 1118
  • [39] Motor fluctuations in Parkinson's disease: pathophysiology and treatment
    Colosimo, C
    De Michele, M
    EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 (01) : 1 - 21
  • [40] A new approach to understand the pathophysiology of Parkinson’s disease
    Atsushi Nambu
    Journal of Neurology, 2005, 252 : iv1 - iv4